Some studies have reported that TNFAIP expression is upregulated in the infiltrating CD4+/CD8+ T cells of patients with HNC, suggesting that TNFAIPs may be involved in the modulation of tumour progression and immunotherapeutic effects. This evidence concerns the gene CD8A and neoplasm.